42J-20342-69212
1 vaccination
3 coded responses
13 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 322 / FL
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Moderna
-
2021-01-12
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness — Feeling: GoodFree text: Muscle weakness in legsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Survey response — day 7, dose 1MedDRA: Muscular weakness — Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Muscle weakness in legsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-02-02
- 2021-04-13
-
2021-07-15
Survey response — 6 months, dose 1MedDRA: Fatigue, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Congestion, fever, fatigueMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-15
Report sent to call center — 6 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-20
- 2022-01-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-15 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Muscle weakness in legs
Release 2 — day 7, dose 1
Systemic reaction (other): Muscle weakness in legs
Release 9 — 6 months, dose 1
Symptoms: Congestion, fever, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | · | ✓ |
| SD | Pyrexia | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release